Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
64.40    -0.60 (-0.92%)
Bid:
64.80
Ask:
65.10
Spread: 0.30 (0.463%)
Market Cap: £568.93m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Notice of Results

2 Sep 2025 09:00

RNS Number : 5490X
IP Group PLC
02 September 2025
 

FOR RELEASE ON

02 September 2025

IP Group - Notice of results and Investor Presentation

IP Group plc (LSE: IPO) ("IP Group"), which invests in breakthrough science and innovation companies with the potential to create a better future for all, announces that it intends to publish its results for the six months ended 30 June 2025 on Wednesday 17 September 2025.

 

The results will be available via the London Stock Exchange's Regulatory News Service (RNS) and on the Investor Relations section of the company's website at  www.ipgroupplc.com.

Key members of IP Group's leadership team will provide a live presentation via the Investor Meet Company platform on 17 September 2025 at 10am.

 

Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation. Investors can sign up to Investor Meet Company for free via: https://www.investormeetcompany.com/ip-group-plc/register-investor. Investors who already follow IP Group on the Investor Meet Company platform will automatically be invited.

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7967 312125

Portland

Alex Donaldson

+44 (0) 7516 729702

 

Notes for editors

 

About IP Group

 

IP Group accelerates the impact of science for a better future. Athe most active UK based, early stage science investorwe develop and support some of the world's most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutionsOur specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOREAPNFEDNSEFA
Date   Source Headline
25th Jun 20263:21 pmRNSForm 8.3 - IP Group PLC
25th Jun 20263:06 pmRNSForm 8.3 - IP Group plc
25th Jun 20262:27 pmRNSForm 8.3 - IP Group plc
25th Jun 20262:08 pmGNWForm 8.3 - IP Group Plc
25th Jun 20261:57 pmEQSForm 8.3 - The Vanguard Group, Inc.: IP Group plc
25th Jun 20261:10 pmRNSForm 8.3 IP Group PLC
25th Jun 202611:21 amRNS20260624_IP Group PLC_8.5 EPT RI_UK_MLI
25th Jun 202610:47 amRNSForm 8.3 IP Group Plc
25th Jun 20267:00 amRNSForm 8.3 - IP Group plc
24th Jun 20263:20 pmRNSForm 8.3 - IP Group plc
24th Jun 20263:19 pmRNSForm 8.3 - IP Group plc
24th Jun 20263:17 pmRNSForm 8.3 - IP Group plc
24th Jun 20263:16 pmRNSForm 8.3 - IP Group plc
24th Jun 20262:48 pmRNSForm 8.3 - IP Group plc
24th Jun 20262:20 pmEQSForm 8.3 - The Vanguard Group, Inc.: IP Group plc
24th Jun 20262:12 pmGNWForm 8.3 - IP Group Plc
24th Jun 202611:53 amRNSForm 8.3 - IP Group PLC
24th Jun 202611:30 amRNSForm 8.5 (EPT/RI) - IP Group plc
24th Jun 202611:27 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - IP GROUP PLC - Ordinary Shares
24th Jun 202611:08 amRNSForm 8.5 (EPT/RI) - IP Group PLC
24th Jun 202610:29 amRNSForm 8.3 IP Group Plc
23rd Jun 20263:54 pmRNSForm 8.3 - IP Group PLC
23rd Jun 20263:20 pmRNSForm 8.3 - IP Group plc
23rd Jun 20263:10 pmRNSForm 8.3 - IP Group plc (OPD)
23rd Jun 20262:46 pmRNSForm 8.3 - IP Group plc
23rd Jun 20262:22 pmGNWForm 8.3 IP Group Plc
23rd Jun 20262:07 pmRNSForm 8.3 IP Group Plc
23rd Jun 20261:57 pmRNSResponse to Possible Offer for IP Group plc
23rd Jun 202611:22 amRNSForm 8.5 (EPT/NON-RI) - IP Group plc
23rd Jun 202611:19 amRNSForm 8.5 (EPT/RI) - IP Group plc
23rd Jun 20269:49 amRNSForm 8.5 (EPT/RI) - IP Group PLC
22nd Jun 20264:27 pmRNSDisclosure Table
22nd Jun 20264:06 pmRNSStatement re Possible Offer
18th Jun 20261:54 pmRNSResult of AGM
16th Jun 20267:00 amRNS-RIstesso starts trial of leramistat in sarcopenia
11th Jun 20267:00 amRNSHolding(s) in Company
3rd Jun 20267:00 amRNSHolding(s) in Company
2nd Jun 20267:00 amRNSHolding(s) in Company
29th May 20267:00 amRNSHolding(s) in Company
29th May 20267:00 amRNSHolding(s) in Company
28th May 20267:00 amRNSHolding(s) in Company
13th May 20265:30 pmRNSNotice of AGM
12th May 20269:10 amRNS-REnterprise reports positive results from P2 trial
11th May 20264:25 pmRNSHolding(s) in Company
11th May 20264:19 pmRNSHolding(s) in Company
7th May 20267:00 amRNSAppointment of Chair Designate
23rd Apr 202612:18 pmRNSDirector/PDMR Shareholding
21st Apr 20267:00 amRNS-RFirst Light announces £25m successful first close
15th Apr 20265:00 pmRNSAnnual Financial Report
14th Apr 20269:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.